These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 28851713)
1. SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation. Cao J; Yu Y; Zhang Z; Chen X; Hu Z; Tong Q; Chang J; Feng XH; Lin X Diabetes; 2018 Jan; 67(1):46-57. PubMed ID: 28851713 [TBL] [Abstract][Full Text] [Related]
2. The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease. Liu X; Yu R; Sun L; Garibotto G; Lin X; Wang Y; Thomas SS; Li R; Hu Z Kidney Int; 2017 Aug; 92(2):336-348. PubMed ID: 28506762 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis. Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223 [TBL] [Abstract][Full Text] [Related]
10. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice. Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370 [TBL] [Abstract][Full Text] [Related]
11. MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice. Wu Z; Jiao P; Huang X; Feng B; Feng Y; Yang S; Hwang P; Du J; Nie Y; Xiao G; Xu H J Clin Invest; 2010 Nov; 120(11):3901-11. PubMed ID: 20921625 [TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Zhang P; Tu B; Wang H; Cao Z; Tang M; Zhang C; Gu B; Li Z; Wang L; Yang Y; Zhao Y; Wang H; Luo J; Deng CX; Gao B; Roeder RG; Zhu WG Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10684-9. PubMed ID: 25009184 [TBL] [Abstract][Full Text] [Related]
13. Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1. Wei D; Tao R; Zhang Y; White MF; Dong XC Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E312-20. PubMed ID: 21081708 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin F Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555 [TBL] [Abstract][Full Text] [Related]
15. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK). Sun WX; Lou K; Chen LJ; Liu SD; Pang SG J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221 [TBL] [Abstract][Full Text] [Related]
16. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice. Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis. Goyal N; Tiwary S; Kesharwani D; Datta M J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059 [TBL] [Abstract][Full Text] [Related]
18. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice. Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1. Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440 [TBL] [Abstract][Full Text] [Related]
20. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1. Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]